ImmuCell Corporation Cash and Restricted Cash
ImmuCell Corporation (ICCC) had Cash and Restricted Cash of $6.00 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-08-14
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.00M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.60M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.76M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.81M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-06-30 | $6.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.60M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.76M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $3.81M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.32M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $960.35K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $978.74K 10-Q · filed 2025-08-14 |
| 2023-09-30 | $1.99M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $1.45M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $3.10M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $5.79M 10-K · filed 2025-03-28 |
| 2022-09-30 | $8.83M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $11.04M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $11.82M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $10.19M 10-K · filed 2024-04-01 |
| 2021-09-30 | $10.50M 10-Q · filed 2022-11-21 |
| 2021-06-30 | $10.70M 10-Q/A · filed 2022-11-21 |
| 2021-03-31 | $6.81M 10-Q/A · filed 2022-11-21 |
| 2020-12-31 | $6.95M 10-K · filed 2023-03-29 |
| 2020-09-30 | $5.32M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $7.60M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $7.91M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $6.29M 10-K · filed 2022-03-30 |
| 2019-09-30 | $2.35M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $1.30M 10-Q · filed 2020-08-12 |
| 2019-03-31 | $10.58M 10-Q · filed 2020-05-13 |
| 2018-12-31 | $2.52M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |